Acinetobacter baumannii is a clinical threat to human health, causing major infection outbreaks 10 worldwide. As new drugs against Gram-negative bacteria do not seem to be forthcoming, and due to 11 the microbial capability of acquiring multi-resistance, there is an urgent need for novel therapeutic 12 targets. Here we have derived a list of new potential targets by means of metabolic reconstruction 13 and modelling of A. baumannii ATCC 19606. By integrating constraint-based modelling with gene 14 expression data, we simulated microbial growth in normal and stressful conditions (i.e. following 15 antibiotic exposure). This allowed us to describe the metabolic reprogramming that occurs in this 16 bacterium when treated with colistin (the currently adopted last-line treatment) and identify a set of 17 genes that are primary targets for developing new drugs against A. baumannii, including colistin-18 resistant strains. It can be anticipated that the metabolic model presented herein will represent a 19 solid and reliable resource for the future treatment of A. baumannii infections. 20 21
Bacteria of the genus Acinetobacter were long considered harmless, environmental organisms, but 3 from the 1960s onward, an increasing number of reports have documented the emergence of 4
Acinetobacter strains of this genus among severely ill, hospitalized patients. These strains showed 5 unusually high levels of resistance to antibiotics that could be used at the time. Also, they gave rise 6 to cross-infections and outbreaks among patients 1 . Recently, resistance to antibiotics in A. 7 baumannii has risen to worrisome proportions (as reviewed in 2 ), from susceptible prior to the 8 1960s, to multidrug-resistant (MDR) (end 1970s), and extended-and pan-drug resistant (XDR, 9 PDR) today. Currently, A baumannii is one of the most prominent organisms that are both antibiotic 10 resistant and involved in health associated infections, the so-called ESKAPE organisms (that 11 include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 12 baumannii, Pseudomonas aeruginosa, and Enterobacter spp. 3 ). 13
One of the last-line treatments for MDR A. baumannii is colistin, a positively charged molecule 14 that, by interacting with the lipid A moiety of lipopolysaccharide (LPS), causes disorganization of 15 the outer membrane. Unfortunately, colistin resistance in A. baumannii has also been reported, thus 16 highlighting the urgency of finding new molecules to face this threat 4 . Although careful 17 monitoring, antimicrobial stewardship and measures to prevent spread in health care institutions are 18 important for controlling A. baumannii infections, new antimicrobial agents and/or strategies are 19 urgently required to eradicate antibiotic resistant strains from affected patients. 20
To address new possible solutions, a system-level study of antibiotic-response in A. baumannii is 21 required. Metabolic network reconstruction and its conversion to a mathematical framework has 22 become a cornerstone for studying the systems biology of metabolism 5 , allowing the examination 23 of the connection between phenotype and genotype and driving biological discoveries. In particular, 24 constraint-based tools (such as Flux Balance Analysis, FBA) enable the estimation of the rate that 25 metabolites' flow through a metabolic network and to compute cellular phenotypes for various 26 growth conditions 6 . Interestingly, by identifying those genes whose deletion is predicted to impair 27 cellular growth, this in silico technique can be used to predict essential genes (EGs) at a genome-1 scale. Following a metabolic modelling approach, several EGs datasets have already been derived 2 for important pathogens such as Helicobacter pylori 7 , Pseudomonas aeruginosa 8 , Mycobacterium 3 tuberculosis 9 , and Staphylococcus aureus 10 . Usually, such predictions are performed simulating 4 growth in an arbitrarily defined medium, accounting for the main nutrients used by the microbe and 5 without imposing any additional constraint to the model. Indeed, the search space of essential genes 6 predicted can be narrowed by imposing additional constraints on the model. One possibility consists 7 of modulating the flux admissible across each reaction on the basis of the expression values of the 8 corresponding genes. By doing so, it is possible to generate context-specific models that reflect the 9 actual set of reactions employed 11 . This approach promises to reduce i) the gap between the 10 predicted and real cellular metabolic landscapes, and ii) the number of false positives/negatives in 11 EGs predictions. Additionally, it might reveal hints for the synergistic use of antibiotics and, in 12 particular, to the possible additional targets that might arise from the adaptation/response of a 13 microbe's metabolism to a single antibiotic. Indeed, changes in gene expression might redirect the 14 cellular metabolic fluxes in such a way that novel and untapped essential reactions may emerge, 15 representing good candidates for a synergic antibiotic. Despite that the use of antibiotics in 16 combination is sometimes questionable, this approach can be considered in cases of severe 17 infections and it has been shown to be effective in the case of Pseudomonas and Acinetobacter spp. 18 12 13 . 19
Here, we explored the system-level metabolic consequences of A. baumannii exposure to colistin. 20
We integrated gene expression data during exposure to colistin 14 with a newly reconstructed 21 genome scale metabolic model, allowing for constraint-based modelling of the type strain ATCC 22 19606. Our data revealed the metabolic reprogramming that occurred in this strain following the 23 establishment of a stressful condition such as the presence of an antibiotic. Furthermore, the 24 metabolic reconstruction provided here represents an important resource for the future 25 understanding of A. baumannii metabolism and for the detection and identification of novel drug 26 
Constraint-based modelling identifies metabolic EGs 11
As already mentioned, the identification of EGs is one of the key-steps in a drug discovery pipeline. 12
Indeed, both general and condition-specific EGs can be distinguished 20 . The formers are required 13 to sustain life under virtually all growth conditions; conversely, under specific constraints, changes 14 of central metabolism may occur leading not only to a change in flux distribution throughout the 15 network, but may also lead to changes in gene essentiality and the appearance of condition-specific 16 essential genes. Hence, we systematically evaluated relevant switches in both unconstrained and 17 constrained models (different scenarios), by imposing the necessary constraints to the metabolic 18 reconstruction. Accordingly, screens for EGs were performed for multiple specific conditions: 19 starting by simply changing the set of available nutrients (i.e. simulating different environmental 20 niches) and then by simulating stressful situations such as antibiotic exposure and mutations (using 21 available expression data in such conditions). 22
Nutrient availability influences identified metabolic EGs. As we were interested in modelling the 23 system in a gradually constrained manner, we initially simulated an arbitrary rich medium, allowing 24 our model to have virtually all the nutrients needed -as likely happens inside of a host 19 . To do so, 25 we set the lower bound of exchange reactions as described in methods. Then we performed in 26 silico gene deletions for each gene in the model. Accordingly, each gene was defined as essential if 1 its elimination destroyed the network's ability to synthesize at least one key biomass molecules (i.e. 2 the model predicts no-growth); otherwise, the gene was considered to be dispensable. Gene 3 essentiality analysis was performed through both FBA and MOMA approaches (see Methods), 4 which both lead to the identification of 57 EGs. Figure 2A shows the values of the ratio between the 5 predicted growth rate of the gene knock-out mutant and the wild type strain (GR ratio, see Methods). 6
The complete list of EGs and their functions is reported in Supplementary Material S5. 7
Next, we repeated EGs prediction by simulating growth in a minimal medium (Simmons medium, 8 as defined in Supplementary Material S1, Supplementary Table 2 ). As shown in Figure 2B , this 9 approach labelled a total of 125 genes as indispensable for growth in this condition (see 10 Supplementary Material S5 for the complete list). Differences emerging from these two simulations 11 highlight how nutrient availability affects cell metabolism and, interestingly, how different 12 environmental pressures influence gene essentiality. Particularly, 57 genes were predicted to be 13 essential under both the tested growth conditions, while 68 are likely to become essential only when 14 limited nutrient availability force the cell to reprogram its metabolic behaviour (i.e. in Simmons 15 medium, Figure 3A ). 16
Predicted EGs are consistent with available experimental datasets. A large body of data exists 17
concerning A. baumannii gene essentiality. Here we used such information both to validate our EGs 18 prediction and to understand whether the identified EGs sets are particular to A. baumannii ATCC 19
20
First we compared the EGs dataset obtained in the arbitrary rich medium to that obtained with an in 21 vivo experiment on A. baumannii ATCC 17978 pathogenesis 21 . By using LB medium (a well-22 known bacteriological rich medium), Wang et al. 21 labelled 481 genes as essentials for that strain. 23
However, not all of them were comparable with our predictions since a large fraction was neither 24 metabolic nor possess an orthologous gene in A. buamannii ATCC 19606. In both cases these genes 25 are absent in iLP844. For the same reason, not all the 57 EGs found through our simulation were 26 comparable with the reported experiment. After performing all these necessary restrictions, we 1 reached the result shown in Figure 3B , i.e. 36 genes have been predicted to be essential by both 2 approaches (in silico and wet-lab) for the two A. baumannii strains considered ( Figure 3B ). A 3 complete description of these EGs is provided in Supplementary Material S5 and represents an 4 experimentally validated dataset in the context of A. baumannii drug target identification. 5
Nevertheless, the two experiments show large discrepancies. The most likely reason for such 6 inconsistency is strains genomic diversity, as previously reported for E. coli strains 22 . 7 Furthermore, our predictions in arbitrary rich medium were compared to those achieved performing 8 the same analysis on the AbyMBEL891 model, an existing model of A. baumannii AYE 19 . In order 9 to implement the simulation, it was necessary to perform a preliminary editing step on the 10 AbyMBEL891 model, as the entire set of gene-reaction-rules was missing from the main 11 reconstruction file. This difficulty in running the analysis highlights the need for a common 12 protocol to be adopted during metabolic reconstruction and a standard to be reached in order to 13 facilitate model re-use and data sharing among research groups. Nevertheless, after including the 14 genes in the Abymbel891 model, we carried out single gene deletion analysis on both models, as 15 described in the methods. As shown in Figure 3C , 40 genes were predicted to be essential in both 16 models, whereas 12 and 46 EGs were specific for A. baumannii ATCC 19606 and AYE, 17 respectively. Information about the gene function are reported in Supplementary Material S5. 18
Comparisons were also carried out between our in silico predictions and wet-lab results in minimal 19 (Simmons) medium. Specifically, we compared our EGs set to that obtained by Dorsey et al. 20 through insertional mutagenesis experiments with A. baumannii ATCC 19606 23 , where the 21 metabolic deficiency of insertion derivatives was subsequently confirmed, identifying essentiality 22 of 10 disrupted genes. Repeating the assay in silico, our model correctly represented the phenotypes 23 of the A. baumannii mutants, with 8 out of the 10 genes predicted as essential by Dorsey and 24 colleagues also shown to be essential in iLP844 ( Figure 3D , Supplementary Material S5). 25
Additionally, in 6 out of the 8 cases, A. baumannii ATCC 19606 model growth was correctly 26 restored (as done in the corresponding wet-lab experiments) by adding to the minimal medium the 1 metabolite(s) whose production was affected by the mutation. 2 3 Antibiotic treatment defines condition-specific models. 4 5
Although a large fraction of the predictions was supported by previous experimental data, a possible 6 source of error, using the methodology described above, stems from the observation that not all the 7 reactions of the model will be active during growth in a given physiological condition. In particular, 8 changes in gene expression are likely to influence the activity rate of the corresponding cellular 9 metabolic reactions, leading to the observation that a given reaction can be considered 'turned on' 10 or 'off' on the basis of the expression levels of the encoding gene(s). Using available computational 11 methodologies, it is possible to modulate the flux across each reaction on the basis of the expression 12 values of the corresponding genes. This allows for taking a picture of the current metabolic state 13 and tightening up the predictive capabilities of the model itself. Accordingly, as the dynamic 14 changes of metabolic reprogramming are likely mirrored by changes in gene essentialities, a 15 possible solution for avoiding or reducing false positives is to merge transcriptomics data of the 16 tested scenario into the genome-scale model. 17
Arguably, one of the most interesting physiological conditions of A. baumannii strains is the 18 exposure to antibiotics and to colistin in particular 14 . Importantly, both the (metabolic) 19 consequences and the occurrence of targets to be used in a synergic treatment are, currently, almost 20 untapped. In order to study the dynamic changes of the metabolic network following antibiotic 21 exposure and to derive a more realistic picture of gene essentiality patterns in a real scenario 22 (antibiotic treatment), we used available transcriptomic data for A. baumannii ATCC 19606 in 23 response to colistin treatment 14 . Up-regulation and down-regulation ratios (and corresponding P-24 values) of genes were combined with the iLP844 by using MADE (Metabolic Adjustment by 25 Differential Expression) 24 . Briefly, MADE uses statistically significant changes in gene expression 26 measurements to determine binary expression states (highly and lowly expressed reactions) i.e. 27 reactions are turned on and off depending on the changes in mRNA transcript levels. Thus, by 1 mapping gene expression data into the model, the in silico metabolic predictions are more 2 consistent with the actual physiological state of the cell. 3
In the experiment by Henry et al. 14 , A. baumannii was grown in two different media, i.e. with and 4 without 2 mg/L of colistin, and then sampled at 15 and 60 minutes after exposure. Following the 5 described approach, we integrated the available transcriptomic data regarding all the metabolic 6 genes embedded in our in-silico reconstruction (i.e. about 80 genes). Accordingly, we obtained four 7 distinct models, each representing the predicted functional metabolic state of the cell at both 15 and 8 60 minutes, treated and untreated with colistin. These models differ in that some of their reactions 9 are (completely) 'turned on' or 'off' according to the measured levels of their corresponding genes. In order to highlight changes in the overall metabolic behaviour and to identify changes on the 16 metabolic rewiring occurring after antibiotic exposure, we compared flux distributions at the two 17 time-points by calculating the flux ratio (RFratio, see Methods) of treated vs. untreated models, for 18 all the reactions. However, FBA only provides one of the possible optimal solution out of many 19 alternative (and feasible) cellular flux distributions. Hence, in order to correctly predict metabolic 20 changes following antibiotic exposure we restricted the feasible solution space by performing Flux 21
Variability Analysis (FVA) 25 . This approach allows estimating the minimum and maximum flux 22 admissible across each reaction (under the same constraints as in FBA) and hence it can be used to 23 estimate the correctness and accuracy of FBA predictions (see Methods). 24
As shown in Supplementary Material S6, according to FVA, the range of admissible flux is 25 sometimes very large (spanning from the minimum -1000 to maximum 1000 mmol/g*h -1 in some 26 cases), revealing the lack of accuracy in some of FBA-derived predictions. We here used FVA 27 outcomes (as described in Methods) to filter out those reactions whose fluxes display little 1 variation. In other words, each reaction was considered for downstream analyses only if both the 2 maximum and minimum FVA predicted fluxes did not differ from the FBA predicted flux by more 3 than 20%. Consequently, we were left with 901 reactions at 15 minutes and 970 reactions at 60 min. 4
It is worth noting that several intervals of admissible flux ranges were tested and we report in 5 Supplementary Materials S1, Supplementary Figure 1 the number of reactions filtered for each set 6 of intervals. After carrying out this preliminary step, we observed the effects of the treatment at the 7 metabolic level (for each reaction) by comparing the flux values in the untreated vs. treated 8 condition. 9
Both qualitative and quantitative flux changes were analysed by dividing the reactions into three 10 categories ('steady', 'increasing', and 'decreasing', see Figure 4 ) according to their trends in the 11 examined experimental conditions. Also, we report a survey of the pathways in which they are 12 involved in and their relative abundance for each category. Reactions' fluxes were considered 13 'steady' if their values did not change in the two conditions, otherwise they were defined to be 14 'increasing' or 'decreasing' according to the corresponding trend. According to the new constraints taken into account, gene essentiality was re-evaluated by 5 calculating growth ratios (FBA and MOMA) at both 15 and 60 minutes after exposure to colistin. 6
As for the analysis involving nutrient availability, shifts in gene essentiality emerged following 7 antibiotic stress. The complete sets of the predicted EGs for each condition have been reported in 8
Supplementary Material S5. As with the previous case, we can easily recognize genes likely to be 9 essential in both conditions (treated and not) and, more interestingly, genes that emerged as 10 essential only after the treatment. Specifically, following 15 minutes of colistin exposure, a total of 11 65 EGs were predicted: 57 were required both in presence and absence of colistin, but an additional 12 16 EGs were marked as condition-specific: 8 related to the non-treated model and 8 related to the 13 treated one, reported in Table 2 and in Figure 5A . 14 The same outline has been depicted in the second time-point condition (60 minutes): we identified 9 15 and 2 condition-specific EGs in the absence and in the presence of the antibiotic, respectively, see 16 Table 2 . Moreover, we found the same set of 57 EGs mentioned above (see Figure 5B ), suggesting 17 that this represents a functionally relevant set of genes for sustaining growth in A. baumannii ATCC 18 19606. Interestingly, however, some genes switch from the 'essential' condition to the 'non-19 essential' one, following the exposure to colistin. 20
The two new sets of EGs show how changes in gene expression induced by the presence of the 21 antibiotic might influence gene essentiality patterns in the strain ATCC 19606 and provide 22 additional, nontrivial targets for drug design in such organism. We also performed additional 23 robustness analyses in order to test whether nutrients depletion occurring in treated and untreated 24 samples during the in vivo experiments could impact the set(s) of predicted EGs. Specifically, the 25 robustness of the number of predicted EGs in each of these conditions (i.e. treated vs. untreated 26 samples) in respect to possible variations in the medium composition was assessed via random 27 permutation. We tested up to 1,000 different nutritional compositions as described in detail in 1 Supplementary Material S1, Supplementary Figure 2 ). The results showed that possible changes in 2 the nutritional environment had only minor implications for the set of predicted EGs. 3 Further, with the aim of discriminating whether the products of all the identified hypothetical EGs 4 are A. baumannii specific or have orthologs in Homo sapiens, meaning they would not represent 5 good candidates for antibiotic treatment development, the sequences of the identified potential EGs 6 were used to probe the human genome. Based on this BLAST 26 search (see Methods), we excluded 7 from further studies those genes presenting more than 30% sequence identity with their human 8 counterparts. Targeting of such genes is non-ideal since they may cause potential side-effects by 9 perturbing critical components in the human body. All BLAST results are reported in Up to now, we have presented how metabolic reconstruction and mathematical modelling can be 9 used to explore the strain's metabolic response during colistin treatment and how it can lead to the 10 identification of novel potential drug targets. Our last attempt is now to illustrate how, starting from 11 the same available experimental data, the model can be employed as a ready-to use blueprint in 12 order to test new hypothesis. 13
As it was reported by Moffatt et al. 28 , the mechanism responsible for colistin resistance is linked to 14 LPS. Specifically, mutations in the lpxA, lpxC, and lpxD genes have been reported as the main 15 cause of LPS loss, thus abolishing the initial charge-based interaction with the antibiotic. Hence, to 16 simulate an A. baumannii LPS (LPS -) deficient and colistin-resistant strain, we removed this 17 component from the biomass formulation in our genome-scale model. Then, to determine which 18 genes are central for the cell's survival in such a condition, we used the transcriptomic data of the 19 mutant strain in the presence/absence of colistin at 60 minutes 14 and mapped the data onto the new 20 LPSmodel. After this, we repeated the EGs prediction pipeline described above. 21
The analysis yielded a total of 62 and 70 EGs in the untreated and treated condition, respectively. 22
Even in this case, the two sets share some elements (59 EGs) that remain mandatory for the cell in 23 the two conditions (listed in Supplementary Material S5). Additionally, it is possible to observe that 24 11 genes become essential (reported in Table 2 ) only after antibiotic exposure: 5 of them were 25 already found to be EGs in the wild type strain while 6 represent specific EGs of the mutant. Since 26 the latter are non-trivial EGs (obtained only through gene expression integration into the model) 27 they have been re-used as seed for an additional BLAST search against the human genome (see 1 Supplementary Material S7). The search led to the identification of 4 genes that do not have 2 orthologs in humans: HMPREF0010_01215 encoding for glutamate-N-acetyltransferase (member 3 of the ornithine acetyltransferase, OAT, family), HMPREF0010_00419, encoding for N-acetyl-4 gamma-glutamyl-phosphate reductase, HMPREF0010_02972 (previously described), and 5 HMPREF0010_01382 encoding for N-acetyl-L-glutamate-kinase, all of which are involved in the 6 arginine biosynthesis pathway, and HMPREF0010_01861 that encodes for a glutamate-racemase. 7
This group of 4 EGs represents a potential achievement obtained from this work as it suggests 8 specific targets to be taken into consideration when developing therapies in combination with 9 colistin. 10 Predicted EGs are common in A. baumannii. Finally, we checked the distribution of EGs 11 predicted for the strain ATCC 19606 within the entire A. baumannii species. The sets of predicted 12
EGs were searched in all of the 1099 A. baumannii genomes sequenced to date, as described in the 13
Methods. The overall result is shown in Supplementary Material S1, Supplementary Figure 3 . The 14 general trend observed was that more than 90% of the genomes analysed possessed the searched 15 queries (identity >30%). Also, our analysis shows that this tendency is kept almost unchanged even 16 when imposing an identity threshold greater than 50%, 70% and 90%. Accordingly, it can be stated 17 that the possible target genes are broadly distributed and their sequence is conserved at the A. 18 baumannii species level. Although we do not have any information about the EGs at such a wide 19 level, this preliminary result is encouraging, since it expresses the possibility that the target genes 20 we indicated for A. baumannii ATCC 19606 are probably common targets in most of A. baumannii 21 type infections. 22
23

Conclusions
24
In this work, we have reconstructed and validated a genome-scale metabolic model of A. baumannii 25 ATCC 19606. The model is comprehensive and accurate, as it covers ~23% of all CDSs in the 26 genome of this microorganism and it was shown to have 88% agreement with Phenotype 1
Microarray growth experiments. Based on the model's reliability, we applied constraint-based 2 modelling to derive a global understanding of the behaviour of this metabolic system. By 3 integrating gene expression data with constraint-based modelling we described the metabolic 4 reprogramming occurring after colistin-exposure in A. baumannii and the changes in the pattern of 5 gene essentiality during this stress condition. All the sets of condition-specific putative target genes 6 that we propose have been compared (and partially validated) with the results obtained from 7 experiments found in the literature. Some of these genes, although not yet experimentally validated, 8 might represent primary targets for future research on the treatment of both the wild type and LPS-9 mutant (i.e. colistin resistant) strains. Our results have practical implications for the identification of 10 new therapeutics as the identified essential genes can be used in drug-design pipelines. Moreover, 11
we showed that the sequences of predicted EGs for the type strain Draft model reconstruction 21
We obtained a draft metabolic model of A. baumannii ATCC 19606 based on the genome 22 annotation using Kbase automated reconstruction method (https://kbase.us/) 29 . This reconstruction 23 was then thoroughly inspected following the main steps listed in Thiele and Palsson 5 , and refined 24 by integrating data from additional functional databases (MetaNetX, Bigg, Seed, KEGG). Further 25 integration was performed by searching for orthologous genes (genes likely having an identical 26 biological function in a different organism) in closely related organisms (Acinetobacter baumanii 27 AYE, Acinetobacter baylyi ADP1, and Escherichia coli) through a BBH (Bidirectional Best Hit) 1 approach (inParanoid 30 ). Information regarding transport proteins was obtained probing the 2 Transporter Classification Data Base (TCDB 31 ) and transportDB 32 . 3 4
In order to predict proper phenotypes, the general biomass producing reaction of Gram negative 5 bacteria automatically generated by Kbase was substituted with a more accurate one that takes into 6 account strain's specific components, which was recovered from the previously reported model of 7 the related strain A. baumannii AYE, AbyMBEL891 19 . 8 9 Metabolic modelling 10 11
The reconstructed model was analysed using COBRApy-0.4.1 COnstraints-Based Reconstruction 12
and Analysis for Python 33 and COBRAToolbox-2.0 34 in MATLAB® R2016a (Mathworks Inc.). 13 Gurobi 6.5.0 (www.gurobi.com) and GLPK 4.32 (http://www.gnu.org/software/glpk/) solvers were 14 used for computational simulations presented. A MATLAB® script to obtain all the results shown 15 in this manuscript is provided as Supplementary Material S8. 16
Two growth media were considered during the in silico simulations: 17
Rich medium: Lower bounds of salts uptake reactions were set to -1000 mmol/g*h -1 in order to 18 mimic non-limiting conditions. Carbon sources uptake reactions were set to -100 mmol/g*h -1 . 19
Simmons medium 35 : Lower bounds of all uptake reactions accounting for the nutrients present in 20
Simmons medium (see Supplementary Material S1, Supplementary Table 2) , were set to -1000 21 mmol/g*h -1 , to mimic non limiting conditions, only the C-source (citrate) was set to -5. 22
23
FVA 24 FVA analysis allows the determination of the span of possible flux variability (i.e. the maximum 25
and minimum values of all the fluxes that satisfy the given constraints) while keeping the same 26 optimal objective value. 27
This approach has been used in this work in order to impose bounds to FBA flux predictions, which 1 are notably non-unique. In fact, for any optimal solution found through FBA there may exist 2 alternate flux distribution patterns yielding the same growth rate. Hence, the space of reliable FBA-3 flux predictions has been restricted by selecting only those that occur in the interval defined as 4 follows: 5 6 (1) with fFBA < 0 7 fFVA, min  fFBA + (0.2* fFBA) ˄ fFVA, max  fFBA -(0.2* fFBA) 8 9
(2) with fFBA > 0 10 fFVA, min  fFBA -(0.2* fFBA) ˄ fFVA, max  fFBA + (0.2* fFBA) 11 12
Gene essentiality and flux ratios calculation 13
Gene essentiality testing was performed by simulating deletion of each gene within the metabolic 14 network and hence setting the associated reactions to carrying no flux (according to the 15 corresponding Gene-Protein-Reaction (GPR) rule). To predict the growth of the mutant strain and 16 determine the set of EGs, we used two different approaches, FBA and MOMA 36 . The main 17 difference between them is that while the first predicts growth yield and metabolic fluxes based on 18 the biological assumption of optimal growth, the second does not assume optimality of growth but 19 approximates metabolic phenotype by performing distance minimization in flux space. The second 20 approach has been shown to be more accurate in predicting lethal phenotypes 36 . The knocked-out 21 gene was defined as 'essential' according to the results obtained computing the ratio (GRratio) 22 between the simulated knocked out strain growth rate (µKO) and the one predicted for the wild type 23 strain (µWT). Formulated as: 24
(3) GRratio = µKO/ µWT 25 26 Following this approach, if GRratio = 0, then the knocked out gene is labelled as essential. 27
Conversely, in case GRratio = 1, the removal of the gene has no effect on the growth phenotype. 1 Finally, when 0 < GRratio < 1, the deleted gene was labelled as fitness-contributing gene, i.e. its 2 removal partially affects the capability of the cell to produce biomass. 3
As MOMA and FBA predictions may lead to different essential gene sets 37, 38, 36 , we used both 4 approaches to compute essential genes in all the conditions tested in this work. Although no major 5 differences were observed, results obtained with both methods are presented throughout the 6 manuscript. 7
In order to evaluate the range of the change in the carried flux of each reaction in the model 8 following colistin exposure, we compute the ratio between the predicted flux in the treated vs. the 9 untreated conditions as follows: 10 11 12
(4) RFratio = (φ Treated / φ Untreated) 13 14
Values of RFratio equal to one indicate that no changes in the activity of the corresponding reactions 15 were observed when simulating growth in the treated vs. the untreated conditions. Conversely, 16 values of RFratio between 0 and 1 or values greater than 1 will indicate a reduced or increased 17 activity of the corresponding reactions in the treated condition, respectively. Finally, negative values 18 of RFratio will indicate those reactions whose directionality is predicted to change after the treatment. 19 20
Transcriptomics data integration and data visualization 21
In order to add transcriptional regulatory rules to the metabolic model, we imported the model from 22 against the human proteome to test their validity as potential drug target in infections with this 7 pathogen, i.e. to exclude any cross-interactions between the drug used for the treatment and human 8 proteome elements. 9
Queries were aligned to the protein sequences of H. sapiens using the default search parameters of 10 the NCBI BLASTP online tool (BLOSUM62 matrix and gap costs equal to Existence 11, Extension 11 1). Results were considered positive (orthologous sequences found) if their sequence identity score 12 value was equal to/greater than 30. 13 In addition, the global distribution of EGs was evaluated at the A. baumannii species level by 14 probing them against all of sequenced genomes retrieved at NCBI ftp site, i.e. 1099 genomes. 15
Particularly, the focus was centred on EGs found in Simmons medium and in rich medium, as well 16 as for those found after 15 and 60 minutes of colistin exposure. BLAST search parameters and 17 analysis of the results were performed as described above. represent MOMA and FBA predictions, respectively. Please note that, in order to make the analysis 4 more comprehensive, also gap-filling genes (i.e. those virtually coding for gap-filling reactions) 5
were included, leading to a total of 1043 simulated knock-outs. 
